other material
confidence high
sentiment negative
materiality 0.85
DENTSPLY SIRONA Inc. (XRAY): restructuring charge — Dentsply Sirona to restate 2021 financials; internal investigation finds misconduct, goodwill impairment $1.0-1.3B
DENTSPLY SIRONA Inc.
- Restating FY2021: Net sales overstated by ~$20M, net income overstated by ~$10M; nine-month 2021 net sales overstated by ~$35M, net income by ~$27M.
- Internal investigation found former CEO/CFO violated Code of Ethics; China team committed intentional wrongdoing by obstructing accounting team.
- Material weaknesses in internal control over financial reporting identified as of Sep 30, 2021 and Dec 31, 2021, still unresolved.
- Expects pre-tax non-cash goodwill and intangible impairment charge of $1.0-1.3B for nine months ended Sep 30, 2022.
- Preliminary Q3 2022 net sales ~$947M; expects sequential net sales to decline low-single digits in Q4 2022.